Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy

• Main Authors: Yani Xu (Author), Lan Yang (Author), Min Li (Author), Haozhou Shu (Author), Na Jia (Author), Yunzhen Gao (Author), Rongying Shi (Author), Xiaojia Yang (Author), Zhirong Zhang (Author), Ling Zhang (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Osteosarcoma is usually resistant to immunotherapy and, thus primarily relies on surgical resection and high-dosage chemotherapy. Unfortunately, less invasive or toxic therapies such as photothermal therapy (PTT) and chemodynamic therapy (CDT) generally failed to show satisfactory outcomes. Adequate...